Clinical Trials Directory

Trials / Unknown

UnknownNCT03643185

Cytokine Profile of Allergic Bronchopulmonary Aspergillosis

Cytokine Profile of Allergic Bronchopulmonary Aspergillosis and Its Relevance to Severity and Exacerbation.

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The main aim of this study is to determine whether the levels of different inflammatory cytokines in the serum and BALF (bronchoalveolar lavage fluid) are relative to the severity and exacerbations of ABPA (allergic bronchopulmonary aspergillosis).

Detailed description

The study would record patients' medical data at baseline and follow them up for different period of time. Updated data would be recorded and blood( or BALF) of the patients would be drawn for tests or stored as whole blood or serum at -80℃ when patients visit the hospital. Then the cytokine (A panel set by the manufacturer) of the serum and BALF would be tested . The secretion ability of peripheral blood mononuclear cells would also be verified. The investigators would then analyze the data and see if any cytokine is relative to the exacerbation or other indicators of the severity of ABPA.

Conditions

Timeline

Start date
2014-12-01
Primary completion
2021-05-04
Completion
2021-05-04
First posted
2018-08-22
Last updated
2021-03-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03643185. Inclusion in this directory is not an endorsement.

Cytokine Profile of Allergic Bronchopulmonary Aspergillosis (NCT03643185) · Clinical Trials Directory